Active Surveillance for Men with Intermediate Risk Prostate Cancer COMMENT

被引:0
|
作者
Chu, Carissa [1 ]
Carroll, Peter [1 ]
机构
[1] Univ Calif San Francisco, UCSF Helen Diller Comprehens Canc Ctr, Dept Urol, San Francisco, CA 94143 USA
来源
JOURNAL OF UROLOGY | 2021年 / 205卷 / 01期
关键词
D O I
10.1097/JU.0000000000001241.01
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:121 / 121
页数:1
相关论文
共 50 条
  • [21] Active Surveillance of Prostate Cancer in African American Men COMMENT
    Sundi, Debasish
    Schaeffer, Edward M.
    UROLOGY, 2014, 84 (06) : 1261 - 1262
  • [22] Intermediate-Term Outcomes for Men with Very Low/Low and Intermediate/High Risk Prostate Cancer Managed by Active Surveillance EDITORIAL COMMENT
    Morash, Chris
    JOURNAL OF UROLOGY, 2017, 198 (03): : 598 - 599
  • [23] Risk Group and Death From Prostate Cancer Implications for Active Surveillance in Men With Favorable Intermediate-Risk Prostate Cancer
    Raldow, Ann C.
    Zhang, Danjie
    Chen, Ming-Hui
    Braccioforte, Michelle H.
    Moran, Brian J.
    D'Amico, Anthony V.
    JAMA ONCOLOGY, 2015, 1 (03) : 334 - 340
  • [24] Active Surveillance for Intermediate Risk Prostate Cancer: Survival Outcomes in the Sunnybrook Experience EDITORIAL COMMENT
    Tosoian, Jeffrey J.
    Alam, Ridwan
    Carter, H. Ballentine
    JOURNAL OF UROLOGY, 2016, 196 (06): : 1658 - 1658
  • [25] Outcomes of Active Surveillance for Men With Intermediate Risk Prostate Cancer: A Population-Based Analysis
    Chandrasekar, Thenappan
    Bowler, Nicholas
    Schneider, Adam
    Goldberg, Hanan
    Mark, James R.
    Trabulsi, Edouard J.
    Lallas, Costas D.
    Gomella, Leonard G.
    UROLOGY, 2021, 155 : 101 - 108
  • [26] THE USE AND OUTCOMES OF MEN WITH NCCN FAVORABLE INTERMEDIATE RISK PROSTATE CANCER MANAGED WITH ACTIVE SURVEILLANCE
    Paudel, Roshan
    Madan, Raghav
    Qi, Ji
    Cher, Michael
    Lane, Brian
    George, Arvin
    Semerjian, Alice
    Ginsburg, Kevin
    JOURNAL OF UROLOGY, 2022, 207 (05): : E745 - E745
  • [27] Metastasis and Mortality in Men With Low- and Intermediate-Risk Prostate Cancer on Active Surveillance
    Courtney, P. Travis
    Deka, Rishi
    Kotha, Nikhil, V
    Cherry, Daniel R.
    Salans, Mia A.
    Nelson, Tyler J.
    Kumar, Abhishek
    Luterstein, Elaine
    Yip, Anthony T.
    Nalawade, Vinit
    Parsons, J. Kellogg
    Kader, A. Karim
    Stewart, Tyler F.
    Rose, Brent S.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2022, 20 (02): : 151 - +
  • [28] Re: Risk Group and Death from Prostate Cancer: Implications for Active Surveillance in Men with Favorable Intermediate-Risk Prostate Cancer
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2016, 196 (02): : 412 - 413
  • [29] Re: Risk Group and Death From Prostate Cancer: Implications for Active Surveillance in Men with Favorable Intermediate-risk Prostate Cancer
    Gandaglia, Giorgio
    Briganti, Alberto
    Montorsi, Francesco
    EUROPEAN UROLOGY, 2016, 69 (02) : 370 - 370
  • [30] Results of active surveillance in low and intermediate risk prostate cancer
    Llorente, Carlos
    Diaz Goizueta, Francisco Javier
    Hernandez, Virginia
    Manuel de la Morena, Jose
    de la Pena, Enrique
    ARCHIVOS ESPANOLES DE UROLOGIA, 2014, 67 (05): : 452 - 456